274 results
CORRESP
INVA
Innoviva Inc
15 Apr 14
Correspondence with SEC
12:00am
on the nature of the arrangement, the nature of its business operations, the contractual terms of the arrangement, and whether those payments are within … of other
authoritative accounting literature, we considered the nature of the payments between the parties and assert that there is a direct correlation
8-K
EX-10.1
INVA
Innoviva Inc
26 May 20
Departure of Directors or Certain Officers
5:14pm
agreement between us with respect to the nature of your employment status. Although your job duties, title, compensation and benefits, as well … as the Company’s personnel policies and procedures to which you will be subject, may change from time to time, the “at-will” nature of your employment may only
S-1/A
EX-10.12
INVA
Innoviva Inc
13 Apr 00
IPO registration (amended)
12:00am
Laboratories, Seller's anti-infective division (the "Business"),
of every kind, nature and description, personal, tangible and intangible, known
or unknown … , taxes and deposits of the Business and all assets
of a similar nature, as set forth and described on SCHEDULE G;
(f) All
8-K
EX-10.1
INVA
Innoviva Inc
2 May 22
Departure of Directors or Certain Officers
5:27pm
cause. This is the full and complete agreement between us with respect to the nature of your employment status. Although your job duties, title … , the “at-will” nature of your employment may only be changed in an express writing signed by you and a Director of the Company. Notwithstanding the foregoing
SC TO-T
EX-99
INVA
Innoviva Inc
25 Jul 22
Third party tender offer statement
8:34am
as confidential or that, given the nature of the information or circumstances surrounding its disclosure, reasonably should be considered confidential … ; and (viii) all materials of any nature prepared by the Receiving Party or others for the Receiving Party containing or reflecting any portion
144
wjx34pavjk
10 Aug 17
Notice of proposed sale of securities
12:00am
8-K
EX-10.2
na5a8 4a0r
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
8-K
EX-10.1
ff565n a0p
11 Sep 18
Departure of Directors or Certain Officers
12:00am
CORRESP
ej5qv nefm6f
9 Jun 06
Correspondence with SEC
12:00am
8-K
EX-10.1
8820y9i63az k4gmmum0
25 Aug 23
Innoviva Appoints Stephen Basso as Chief Financial Officer
5:24pm
8-K
EX-10.1
1oo4bu74lle y5
29 Nov 10
GlaxoSmithKline to Increase Its Shareholding in Theravance
12:00am
8-K
EX-2.1
h2739h
11 Jul 22
Innoviva to Acquire La Jolla Pharmaceutical Company
7:38am
SC TO-C
EX-2.1
kw6pys1qf5v2ec3 hg7
11 Jul 22
Information about tender offer
3:46pm
8-K
4dk sbwhh2l574k430
14 Dec 20
Entry into a Material Definitive Agreement
6:05am